跳至主要内容
临床试验/NCT00135512
NCT00135512已完成2 期

An Open-Label, Multi-Center, Phase II Study Evaluating the Safety and Efficacy of 323U66 SR in Patients With Depression

GlaxoSmithKline7 个研究点 分布在 1 个国家目标入组 234 人开始时间: 2004年12月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
234
试验地点
7
主要终点
Change From Baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at Week 8 in Observed Cases

研究概览

简要总结

This study was designed to evaluate the efficacy and safety in major depressive disorder patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change From Baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at Week 8 in Observed Cases

时间窗: Baseline (Week 0) and Week 8

The MADRS is a semi-structured interview rating scale for depression that assesses 10 symptoms. The scale is composed of 10 questions (1, apparent sadness; 2, reported sadness; 3, inner tension; 4, reduced sleep; 5, reduced appetite; 6, concentration difficulties; 7, lassitude; 8, inability to feel; 9, pessimistic thoughts; 10, suicidal thoughts) with a fixed 7 point scale (0, no depression; 60, severely depressed). Total score ranges from 0-60. A higher score indicates more depressive symptoms. MADRS Response was defined as a reduction in MADRS score from Baseline. Change from Baseline in the total score was calculated as the value at Week 8 minus the value at Baseline. Baseline was defined as value at Week 0.

次要结局

  • Change From Baseline in the MADRS Total Score at Week 52 in Observed Cases(Baseline (Week 0) and Week 52)
  • Change From Baseline in the Hamilton Depression Rating Scale (HAM-D; 17 Items) Total Score at Weeks 8 and 52 in Observed Cases(Baseline (Week 0) and Week 8, 52)
  • Percentage of Participants Who Were Clinical Global Impression Global Improvement (CGI-I) Responders at Weeks 8 and 52 in Observed Cases(Week 8, 52)
  • Change From Baseline in CGI Severity of Illness (CGI-SI) at Weeks 8 and 52 in Observed Cases(Baseline (Week 0) and Week 8, 52)
  • Change From Baseline in the Sheehan Disability Scale (SDISS) Total Score at Weeks 8 and 52 in Observed Cases(Baseline (Week 0) and Week 8, 52)
  • Change From Baseline in the Motivation Energy Inventory Short Form (MEI-SF) Total Score at Weeks 8 and 52 in Observed Cases(Baseline (Week 0) and Week 8, 52)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Study Of 323U66 SR In Major Depressive Disorder | 临床试验